v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   85,439,630    
Beginning balance at Dec. 31, 2024 $ (17,345,745) $ 85,440 $ 152,402,938 $ (169,834,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 94,450   94,450  
Net loss (4,040,283)     (4,040,283)
Ending balance (in shares) at Mar. 31, 2025   85,439,630    
Ending balance at Mar. 31, 2025 (21,291,578) $ 85,440 152,497,388 (173,874,406)
Beginning balance (in shares) at Dec. 31, 2024   85,439,630    
Beginning balance at Dec. 31, 2024 (17,345,745) $ 85,440 152,402,938 (169,834,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (11,085,202)      
Ending balance (in shares) at Jun. 30, 2025   85,439,630    
Ending balance at Jun. 30, 2025 (28,242,047) $ 85,440 152,591,838 (180,919,325)
Beginning balance (in shares) at Mar. 31, 2025   85,439,630    
Beginning balance at Mar. 31, 2025 (21,291,578) $ 85,440 152,497,388 (173,874,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 94,450   94,450  
Net loss (7,044,919)     (7,044,919)
Ending balance (in shares) at Jun. 30, 2025   85,439,630    
Ending balance at Jun. 30, 2025 $ (28,242,047) $ 85,440 152,591,838 (180,919,325)
Beginning balance (in shares) at Dec. 31, 2025 116,509,480 116,509,480    
Beginning balance at Dec. 31, 2025 $ 61,560,839 $ 116,509 266,021,748 (204,577,418)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 1,826,746   1,826,746  
Net loss (13,251,490)     (13,251,490)
Ending balance (in shares) at Mar. 31, 2026   116,509,480    
Ending balance at Mar. 31, 2026 $ 50,136,095 $ 116,509 267,848,494 (217,828,908)
Beginning balance (in shares) at Dec. 31, 2025 116,509,480 116,509,480    
Beginning balance at Dec. 31, 2025 $ 61,560,839 $ 116,509 266,021,748 (204,577,418)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (29,972,254)      
Ending balance (in shares) at Jun. 30, 2026 143,726,603 143,726,603    
Ending balance at Jun. 30, 2026 $ 322,603,907 $ 143,726 557,009,853 (234,549,672)
Beginning balance (in shares) at Mar. 31, 2026   116,509,480    
Beginning balance at Mar. 31, 2026 50,136,095 $ 116,509 267,848,494 (217,828,908)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 2,428,006   2,428,006  
Issuance of common stock in connection with initial public offering, net of underwriting fees and offering costs (in shares)   23,000,000    
Issuance of common stock in connection with initial public offering, net of underwriting fees and offering costs 286,760,570 $ 23,000 286,737,570  
Issuance of common stock upon exercise of warrants (in shares)   4,217,123    
Issuance of common stock upon exercise of warrants 0 $ 4,217 (4,217)  
Net loss $ (16,720,764)     (16,720,764)
Ending balance (in shares) at Jun. 30, 2026 143,726,603 143,726,603    
Ending balance at Jun. 30, 2026 $ 322,603,907 $ 143,726 $ 557,009,853 $ (234,549,672)